When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
IPATF - ImmunoPrecise Genmab inks technology partnership for infectious diseases
ImmunoPrecise Antibodies Ltd.
ImmunoPrecise (IPATF) has entered into a research agreement with Genmab (GMAB), wherein IPA will generate bispecific antibody combinations using Genmab's proprietary DuoBody platform and IPA's proprietary antibodies in the field of infectious disease.As a part of the partnership, Genmab and IPA will negotiate an agreement for the commercial use of resulting DuoBody products.